GoHealth Expected to Post $1.12 Per Share Loss, Revenue to Plunge 77%
GOCO sits 19% above its 52-week low of $1.31.
Summary
GoHealth, Inc. is expected to report a significant loss of $1.12 per share and a substantial 76.9% decrease in quarterly revenue to $89.91 million for the period ending December 31, 2025. This dire earnings preview follows closely on the heels of a Nasdaq delisting notice issued just last week due to the company failing to meet the minimum market value requirement. The projected loss of $1.12 per share is extremely material relative to the company's current stock price of $1.56, indicating severe financial deterioration. The massive revenue decline further underscores the operational challenges and reinforces the negative sentiment surrounding the company's financial viability, especially after the recent delisting warning. Investors will be closely watching the actual earnings report on March 30 (estimated) for confirmation of these expectations and any management commentary on the company's strategy to address its financial challenges and Nasdaq compliance.
At the time of this announcement, GOCO was trading at $1.56 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $25.1M. The 52-week trading range was $1.31 to $13.11. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Reuters.